Global Pharmaceutical Excipients for Non-injection Market Growth 2026-2032
The global Pharmaceutical Excipients for Non-injection market size is predicted to grow from US$ 5971 million in 2025 to US$ 11540 million in 2032; it is expected to grow at a CAGR of 10.1% from 2026 to 2032.
Pharmaceutical excipients are the inactive substances that are added to a drug formulation to improve its stability, bioavailability, palatability, and other properties. They are generally regarded as safe (GRAS) by regulatory agencies and are used in various dosage forms, such as tablets, capsules, oral liquids, topical creams, and inhalers.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Pharmaceutical Excipients for Non-injection Industry Forecast” looks at past sales and reviews total world Pharmaceutical Excipients for Non-injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Excipients for Non-injection sales for 2026 through 2032. With Pharmaceutical Excipients for Non-injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Excipients for Non-injection industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical Excipients for Non-injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Excipients for Non-injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical Excipients for Non-injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Excipients for Non-injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Excipients for Non-injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Excipients for Non-injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Pharmaceutical Excipients for Non-injection market?
What factors are driving Pharmaceutical Excipients for Non-injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pharmaceutical Excipients for Non-injection market opportunities vary by end market size?
How does Pharmaceutical Excipients for Non-injection break out by Type, by Application?
Pharmaceutical excipients are the inactive substances that are added to a drug formulation to improve its stability, bioavailability, palatability, and other properties. They are generally regarded as safe (GRAS) by regulatory agencies and are used in various dosage forms, such as tablets, capsules, oral liquids, topical creams, and inhalers.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Pharmaceutical Excipients for Non-injection Industry Forecast” looks at past sales and reviews total world Pharmaceutical Excipients for Non-injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Excipients for Non-injection sales for 2026 through 2032. With Pharmaceutical Excipients for Non-injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Excipients for Non-injection industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical Excipients for Non-injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Excipients for Non-injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical Excipients for Non-injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Excipients for Non-injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Excipients for Non-injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Excipients for Non-injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Binders
- Disintegrants
- Lubricants
- Fillers
- Others
- Tablets
- Capsules
- Oral Liquids
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Dow
- Nippon Fine Chemical
- Nanjing Well Pharmaceutical
- Jiangsu Maxim Biological
- NOF
- Croda
- Jiangsu Poly Pharmaceutical
- Er Kang Pharmaceutical
- Guangzhou Hanfang Pharmaceutical
- Pfanstiehl
- Xi'an Libang Pharmaceutical
- Zhejiang Tianyushan Medicinal Oil
What is the 10-year outlook for the global Pharmaceutical Excipients for Non-injection market?
What factors are driving Pharmaceutical Excipients for Non-injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pharmaceutical Excipients for Non-injection market opportunities vary by end market size?
How does Pharmaceutical Excipients for Non-injection break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pharmaceutical Excipients for Non-injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Pharmaceutical Excipients for Non-injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Pharmaceutical Excipients for Non-injection by Country/Region, 2021, 2025 & 2032
2.2 Pharmaceutical Excipients for Non-injection Segment by Type
2.2.1 Binders
2.2.2 Disintegrants
2.2.3 Lubricants
2.2.4 Fillers
2.2.5 Others
2.2.6 Pharmaceutical Excipients for Non-injection Sales by Type
2.2.6.1 Global Pharmaceutical Excipients for Non-injection Sales Market Share by Type (2021-2026)
2.2.6.2 Global Pharmaceutical Excipients for Non-injection Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global Pharmaceutical Excipients for Non-injection Sale Price by Type (2021-2026)
2.3 Pharmaceutical Excipients for Non-injection Segment by Application
2.3.1 Tablets
2.3.2 Capsules
2.3.3 Oral Liquids
2.3.4 Others
2.3.5 Pharmaceutical Excipients for Non-injection Sales by Application
2.3.5.1 Global Pharmaceutical Excipients for Non-injection Sale Market Share by Application (2021-2026)
2.3.5.2 Global Pharmaceutical Excipients for Non-injection Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Pharmaceutical Excipients for Non-injection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Pharmaceutical Excipients for Non-injection Breakdown Data by Company
3.1.1 Global Pharmaceutical Excipients for Non-injection Annual Sales by Company (2021-2026)
3.1.2 Global Pharmaceutical Excipients for Non-injection Sales Market Share by Company (2021-2026)
3.2 Global Pharmaceutical Excipients for Non-injection Annual Revenue by Company (2021-2026)
3.2.1 Global Pharmaceutical Excipients for Non-injection Revenue by Company (2021-2026)
3.2.2 Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Company (2021-2026)
3.3 Global Pharmaceutical Excipients for Non-injection Sale Price by Company
3.4 Key Manufacturers Pharmaceutical Excipients for Non-injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pharmaceutical Excipients for Non-injection Product Location Distribution
3.4.2 Players Pharmaceutical Excipients for Non-injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PHARMACEUTICAL EXCIPIENTS FOR NON-INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Pharmaceutical Excipients for Non-injection Market Size by Geographic Region (2021-2026)
4.1.1 Global Pharmaceutical Excipients for Non-injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Pharmaceutical Excipients for Non-injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Pharmaceutical Excipients for Non-injection Market Size by Country/Region (2021-2026)
4.2.1 Global Pharmaceutical Excipients for Non-injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global Pharmaceutical Excipients for Non-injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Pharmaceutical Excipients for Non-injection Sales Growth
4.4 APAC Pharmaceutical Excipients for Non-injection Sales Growth
4.5 Europe Pharmaceutical Excipients for Non-injection Sales Growth
4.6 Middle East & Africa Pharmaceutical Excipients for Non-injection Sales Growth
5 AMERICAS
5.1 Americas Pharmaceutical Excipients for Non-injection Sales by Country
5.1.1 Americas Pharmaceutical Excipients for Non-injection Sales by Country (2021-2026)
5.1.2 Americas Pharmaceutical Excipients for Non-injection Revenue by Country (2021-2026)
5.2 Americas Pharmaceutical Excipients for Non-injection Sales by Type (2021-2026)
5.3 Americas Pharmaceutical Excipients for Non-injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical Excipients for Non-injection Sales by Region
6.1.1 APAC Pharmaceutical Excipients for Non-injection Sales by Region (2021-2026)
6.1.2 APAC Pharmaceutical Excipients for Non-injection Revenue by Region (2021-2026)
6.2 APAC Pharmaceutical Excipients for Non-injection Sales by Type (2021-2026)
6.3 APAC Pharmaceutical Excipients for Non-injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pharmaceutical Excipients for Non-injection by Country
7.1.1 Europe Pharmaceutical Excipients for Non-injection Sales by Country (2021-2026)
7.1.2 Europe Pharmaceutical Excipients for Non-injection Revenue by Country (2021-2026)
7.2 Europe Pharmaceutical Excipients for Non-injection Sales by Type (2021-2026)
7.3 Europe Pharmaceutical Excipients for Non-injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pharmaceutical Excipients for Non-injection by Country
8.1.1 Middle East & Africa Pharmaceutical Excipients for Non-injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa Pharmaceutical Excipients for Non-injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Pharmaceutical Excipients for Non-injection Sales by Type (2021-2026)
8.3 Middle East & Africa Pharmaceutical Excipients for Non-injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pharmaceutical Excipients for Non-injection
10.3 Manufacturing Process Analysis of Pharmaceutical Excipients for Non-injection
10.4 Industry Chain Structure of Pharmaceutical Excipients for Non-injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pharmaceutical Excipients for Non-injection Distributors
11.3 Pharmaceutical Excipients for Non-injection Customer
12 WORLD FORECAST REVIEW FOR PHARMACEUTICAL EXCIPIENTS FOR NON-INJECTION BY GEOGRAPHIC REGION
12.1 Global Pharmaceutical Excipients for Non-injection Market Size Forecast by Region
12.1.1 Global Pharmaceutical Excipients for Non-injection Forecast by Region (2027-2032)
12.1.2 Global Pharmaceutical Excipients for Non-injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Pharmaceutical Excipients for Non-injection Forecast by Type (2027-2032)
12.7 Global Pharmaceutical Excipients for Non-injection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Dow
13.1.1 Dow Company Information
13.1.2 Dow Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
13.1.3 Dow Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Dow Main Business Overview
13.1.5 Dow Latest Developments
13.2 Nippon Fine Chemical
13.2.1 Nippon Fine Chemical Company Information
13.2.2 Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
13.2.3 Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Nippon Fine Chemical Main Business Overview
13.2.5 Nippon Fine Chemical Latest Developments
13.3 Nanjing Well Pharmaceutical
13.3.1 Nanjing Well Pharmaceutical Company Information
13.3.2 Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
13.3.3 Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Nanjing Well Pharmaceutical Main Business Overview
13.3.5 Nanjing Well Pharmaceutical Latest Developments
13.4 Jiangsu Maxim Biological
13.4.1 Jiangsu Maxim Biological Company Information
13.4.2 Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
13.4.3 Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Jiangsu Maxim Biological Main Business Overview
13.4.5 Jiangsu Maxim Biological Latest Developments
13.5 NOF
13.5.1 NOF Company Information
13.5.2 NOF Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
13.5.3 NOF Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 NOF Main Business Overview
13.5.5 NOF Latest Developments
13.6 Croda
13.6.1 Croda Company Information
13.6.2 Croda Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
13.6.3 Croda Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Croda Main Business Overview
13.6.5 Croda Latest Developments
13.7 Jiangsu Poly Pharmaceutical
13.7.1 Jiangsu Poly Pharmaceutical Company Information
13.7.2 Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
13.7.3 Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Jiangsu Poly Pharmaceutical Main Business Overview
13.7.5 Jiangsu Poly Pharmaceutical Latest Developments
13.8 Er Kang Pharmaceutical
13.8.1 Er Kang Pharmaceutical Company Information
13.8.2 Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
13.8.3 Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Er Kang Pharmaceutical Main Business Overview
13.8.5 Er Kang Pharmaceutical Latest Developments
13.9 Guangzhou Hanfang Pharmaceutical
13.9.1 Guangzhou Hanfang Pharmaceutical Company Information
13.9.2 Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
13.9.3 Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Guangzhou Hanfang Pharmaceutical Main Business Overview
13.9.5 Guangzhou Hanfang Pharmaceutical Latest Developments
13.10 Pfanstiehl
13.10.1 Pfanstiehl Company Information
13.10.2 Pfanstiehl Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
13.10.3 Pfanstiehl Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Pfanstiehl Main Business Overview
13.10.5 Pfanstiehl Latest Developments
13.11 Xi'an Libang Pharmaceutical
13.11.1 Xi'an Libang Pharmaceutical Company Information
13.11.2 Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
13.11.3 Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Xi'an Libang Pharmaceutical Main Business Overview
13.11.5 Xi'an Libang Pharmaceutical Latest Developments
13.12 Zhejiang Tianyushan Medicinal Oil
13.12.1 Zhejiang Tianyushan Medicinal Oil Company Information
13.12.2 Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
13.12.3 Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Zhejiang Tianyushan Medicinal Oil Main Business Overview
13.12.5 Zhejiang Tianyushan Medicinal Oil Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pharmaceutical Excipients for Non-injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Pharmaceutical Excipients for Non-injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Pharmaceutical Excipients for Non-injection by Country/Region, 2021, 2025 & 2032
2.2 Pharmaceutical Excipients for Non-injection Segment by Type
2.2.1 Binders
2.2.2 Disintegrants
2.2.3 Lubricants
2.2.4 Fillers
2.2.5 Others
2.2.6 Pharmaceutical Excipients for Non-injection Sales by Type
2.2.6.1 Global Pharmaceutical Excipients for Non-injection Sales Market Share by Type (2021-2026)
2.2.6.2 Global Pharmaceutical Excipients for Non-injection Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global Pharmaceutical Excipients for Non-injection Sale Price by Type (2021-2026)
2.3 Pharmaceutical Excipients for Non-injection Segment by Application
2.3.1 Tablets
2.3.2 Capsules
2.3.3 Oral Liquids
2.3.4 Others
2.3.5 Pharmaceutical Excipients for Non-injection Sales by Application
2.3.5.1 Global Pharmaceutical Excipients for Non-injection Sale Market Share by Application (2021-2026)
2.3.5.2 Global Pharmaceutical Excipients for Non-injection Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Pharmaceutical Excipients for Non-injection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Pharmaceutical Excipients for Non-injection Breakdown Data by Company
3.1.1 Global Pharmaceutical Excipients for Non-injection Annual Sales by Company (2021-2026)
3.1.2 Global Pharmaceutical Excipients for Non-injection Sales Market Share by Company (2021-2026)
3.2 Global Pharmaceutical Excipients for Non-injection Annual Revenue by Company (2021-2026)
3.2.1 Global Pharmaceutical Excipients for Non-injection Revenue by Company (2021-2026)
3.2.2 Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Company (2021-2026)
3.3 Global Pharmaceutical Excipients for Non-injection Sale Price by Company
3.4 Key Manufacturers Pharmaceutical Excipients for Non-injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pharmaceutical Excipients for Non-injection Product Location Distribution
3.4.2 Players Pharmaceutical Excipients for Non-injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PHARMACEUTICAL EXCIPIENTS FOR NON-INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Pharmaceutical Excipients for Non-injection Market Size by Geographic Region (2021-2026)
4.1.1 Global Pharmaceutical Excipients for Non-injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Pharmaceutical Excipients for Non-injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Pharmaceutical Excipients for Non-injection Market Size by Country/Region (2021-2026)
4.2.1 Global Pharmaceutical Excipients for Non-injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global Pharmaceutical Excipients for Non-injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Pharmaceutical Excipients for Non-injection Sales Growth
4.4 APAC Pharmaceutical Excipients for Non-injection Sales Growth
4.5 Europe Pharmaceutical Excipients for Non-injection Sales Growth
4.6 Middle East & Africa Pharmaceutical Excipients for Non-injection Sales Growth
5 AMERICAS
5.1 Americas Pharmaceutical Excipients for Non-injection Sales by Country
5.1.1 Americas Pharmaceutical Excipients for Non-injection Sales by Country (2021-2026)
5.1.2 Americas Pharmaceutical Excipients for Non-injection Revenue by Country (2021-2026)
5.2 Americas Pharmaceutical Excipients for Non-injection Sales by Type (2021-2026)
5.3 Americas Pharmaceutical Excipients for Non-injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical Excipients for Non-injection Sales by Region
6.1.1 APAC Pharmaceutical Excipients for Non-injection Sales by Region (2021-2026)
6.1.2 APAC Pharmaceutical Excipients for Non-injection Revenue by Region (2021-2026)
6.2 APAC Pharmaceutical Excipients for Non-injection Sales by Type (2021-2026)
6.3 APAC Pharmaceutical Excipients for Non-injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pharmaceutical Excipients for Non-injection by Country
7.1.1 Europe Pharmaceutical Excipients for Non-injection Sales by Country (2021-2026)
7.1.2 Europe Pharmaceutical Excipients for Non-injection Revenue by Country (2021-2026)
7.2 Europe Pharmaceutical Excipients for Non-injection Sales by Type (2021-2026)
7.3 Europe Pharmaceutical Excipients for Non-injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pharmaceutical Excipients for Non-injection by Country
8.1.1 Middle East & Africa Pharmaceutical Excipients for Non-injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa Pharmaceutical Excipients for Non-injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Pharmaceutical Excipients for Non-injection Sales by Type (2021-2026)
8.3 Middle East & Africa Pharmaceutical Excipients for Non-injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pharmaceutical Excipients for Non-injection
10.3 Manufacturing Process Analysis of Pharmaceutical Excipients for Non-injection
10.4 Industry Chain Structure of Pharmaceutical Excipients for Non-injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pharmaceutical Excipients for Non-injection Distributors
11.3 Pharmaceutical Excipients for Non-injection Customer
12 WORLD FORECAST REVIEW FOR PHARMACEUTICAL EXCIPIENTS FOR NON-INJECTION BY GEOGRAPHIC REGION
12.1 Global Pharmaceutical Excipients for Non-injection Market Size Forecast by Region
12.1.1 Global Pharmaceutical Excipients for Non-injection Forecast by Region (2027-2032)
12.1.2 Global Pharmaceutical Excipients for Non-injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Pharmaceutical Excipients for Non-injection Forecast by Type (2027-2032)
12.7 Global Pharmaceutical Excipients for Non-injection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Dow
13.1.1 Dow Company Information
13.1.2 Dow Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
13.1.3 Dow Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Dow Main Business Overview
13.1.5 Dow Latest Developments
13.2 Nippon Fine Chemical
13.2.1 Nippon Fine Chemical Company Information
13.2.2 Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
13.2.3 Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Nippon Fine Chemical Main Business Overview
13.2.5 Nippon Fine Chemical Latest Developments
13.3 Nanjing Well Pharmaceutical
13.3.1 Nanjing Well Pharmaceutical Company Information
13.3.2 Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
13.3.3 Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Nanjing Well Pharmaceutical Main Business Overview
13.3.5 Nanjing Well Pharmaceutical Latest Developments
13.4 Jiangsu Maxim Biological
13.4.1 Jiangsu Maxim Biological Company Information
13.4.2 Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
13.4.3 Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Jiangsu Maxim Biological Main Business Overview
13.4.5 Jiangsu Maxim Biological Latest Developments
13.5 NOF
13.5.1 NOF Company Information
13.5.2 NOF Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
13.5.3 NOF Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 NOF Main Business Overview
13.5.5 NOF Latest Developments
13.6 Croda
13.6.1 Croda Company Information
13.6.2 Croda Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
13.6.3 Croda Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Croda Main Business Overview
13.6.5 Croda Latest Developments
13.7 Jiangsu Poly Pharmaceutical
13.7.1 Jiangsu Poly Pharmaceutical Company Information
13.7.2 Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
13.7.3 Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Jiangsu Poly Pharmaceutical Main Business Overview
13.7.5 Jiangsu Poly Pharmaceutical Latest Developments
13.8 Er Kang Pharmaceutical
13.8.1 Er Kang Pharmaceutical Company Information
13.8.2 Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
13.8.3 Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Er Kang Pharmaceutical Main Business Overview
13.8.5 Er Kang Pharmaceutical Latest Developments
13.9 Guangzhou Hanfang Pharmaceutical
13.9.1 Guangzhou Hanfang Pharmaceutical Company Information
13.9.2 Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
13.9.3 Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Guangzhou Hanfang Pharmaceutical Main Business Overview
13.9.5 Guangzhou Hanfang Pharmaceutical Latest Developments
13.10 Pfanstiehl
13.10.1 Pfanstiehl Company Information
13.10.2 Pfanstiehl Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
13.10.3 Pfanstiehl Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Pfanstiehl Main Business Overview
13.10.5 Pfanstiehl Latest Developments
13.11 Xi'an Libang Pharmaceutical
13.11.1 Xi'an Libang Pharmaceutical Company Information
13.11.2 Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
13.11.3 Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Xi'an Libang Pharmaceutical Main Business Overview
13.11.5 Xi'an Libang Pharmaceutical Latest Developments
13.12 Zhejiang Tianyushan Medicinal Oil
13.12.1 Zhejiang Tianyushan Medicinal Oil Company Information
13.12.2 Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
13.12.3 Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Zhejiang Tianyushan Medicinal Oil Main Business Overview
13.12.5 Zhejiang Tianyushan Medicinal Oil Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pharmaceutical Excipients for Non-injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Pharmaceutical Excipients for Non-injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Binders
Table 4. Major Players of Disintegrants
Table 5. Major Players of Lubricants
Table 6. Major Players of Fillers
Table 7. Major Players of Others
Table 8. Global Pharmaceutical Excipients for Non-injection Sales by Type (2021-2026) & (K Units)
Table 9. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Type (2021-2026)
Table 10. Global Pharmaceutical Excipients for Non-injection Revenue by Type (2021-2026) & ($ million)
Table 11. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Type (2021-2026)
Table 12. Global Pharmaceutical Excipients for Non-injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 13. Global Pharmaceutical Excipients for Non-injection Sale by Application (2021-2026) & (K Units)
Table 14. Global Pharmaceutical Excipients for Non-injection Sale Market Share by Application (2021-2026)
Table 15. Global Pharmaceutical Excipients for Non-injection Revenue by Application (2021-2026) & ($ million)
Table 16. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Application (2021-2026)
Table 17. Global Pharmaceutical Excipients for Non-injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 18. Global Pharmaceutical Excipients for Non-injection Sales by Company (2021-2026) & (K Units)
Table 19. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Company (2021-2026)
Table 20. Global Pharmaceutical Excipients for Non-injection Revenue by Company (2021-2026) & ($ millions)
Table 21. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Company (2021-2026)
Table 22. Global Pharmaceutical Excipients for Non-injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 23. Key Manufacturers Pharmaceutical Excipients for Non-injection Producing Area Distribution and Sales Area
Table 24. Players Pharmaceutical Excipients for Non-injection Products Offered
Table 25. Pharmaceutical Excipients for Non-injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Pharmaceutical Excipients for Non-injection Sales by Geographic Region (2021-2026) & (K Units)
Table 29. Global Pharmaceutical Excipients for Non-injection Sales Market Share Geographic Region (2021-2026)
Table 30. Global Pharmaceutical Excipients for Non-injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 31. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Geographic Region (2021-2026)
Table 32. Global Pharmaceutical Excipients for Non-injection Sales by Country/Region (2021-2026) & (K Units)
Table 33. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Country/Region (2021-2026)
Table 34. Global Pharmaceutical Excipients for Non-injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 35. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Country/Region (2021-2026)
Table 36. Americas Pharmaceutical Excipients for Non-injection Sales by Country (2021-2026) & (K Units)
Table 37. Americas Pharmaceutical Excipients for Non-injection Sales Market Share by Country (2021-2026)
Table 38. Americas Pharmaceutical Excipients for Non-injection Revenue by Country (2021-2026) & ($ millions)
Table 39. Americas Pharmaceutical Excipients for Non-injection Sales by Type (2021-2026) & (K Units)
Table 40. Americas Pharmaceutical Excipients for Non-injection Sales by Application (2021-2026) & (K Units)
Table 41. APAC Pharmaceutical Excipients for Non-injection Sales by Region (2021-2026) & (K Units)
Table 42. APAC Pharmaceutical Excipients for Non-injection Sales Market Share by Region (2021-2026)
Table 43. APAC Pharmaceutical Excipients for Non-injection Revenue by Region (2021-2026) & ($ millions)
Table 44. APAC Pharmaceutical Excipients for Non-injection Sales by Type (2021-2026) & (K Units)
Table 45. APAC Pharmaceutical Excipients for Non-injection Sales by Application (2021-2026) & (K Units)
Table 46. Europe Pharmaceutical Excipients for Non-injection Sales by Country (2021-2026) & (K Units)
Table 47. Europe Pharmaceutical Excipients for Non-injection Revenue by Country (2021-2026) & ($ millions)
Table 48. Europe Pharmaceutical Excipients for Non-injection Sales by Type (2021-2026) & (K Units)
Table 49. Europe Pharmaceutical Excipients for Non-injection Sales by Application (2021-2026) & (K Units)
Table 50. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales by Country (2021-2026) & (K Units)
Table 51. Middle East & Africa Pharmaceutical Excipients for Non-injection Revenue Market Share by Country (2021-2026)
Table 52. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales by Type (2021-2026) & (K Units)
Table 53. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales by Application (2021-2026) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Pharmaceutical Excipients for Non-injection
Table 55. Key Market Challenges & Risks of Pharmaceutical Excipients for Non-injection
Table 56. Key Industry Trends of Pharmaceutical Excipients for Non-injection
Table 57. Pharmaceutical Excipients for Non-injection Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Pharmaceutical Excipients for Non-injection Distributors List
Table 60. Pharmaceutical Excipients for Non-injection Customer List
Table 61. Global Pharmaceutical Excipients for Non-injection Sales Forecast by Region (2027-2032) & (K Units)
Table 62. Global Pharmaceutical Excipients for Non-injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 63. Americas Pharmaceutical Excipients for Non-injection Sales Forecast by Country (2027-2032) & (K Units)
Table 64. Americas Pharmaceutical Excipients for Non-injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 65. APAC Pharmaceutical Excipients for Non-injection Sales Forecast by Region (2027-2032) & (K Units)
Table 66. APAC Pharmaceutical Excipients for Non-injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 67. Europe Pharmaceutical Excipients for Non-injection Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Europe Pharmaceutical Excipients for Non-injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales Forecast by Country (2027-2032) & (K Units)
Table 70. Middle East & Africa Pharmaceutical Excipients for Non-injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. Global Pharmaceutical Excipients for Non-injection Sales Forecast by Type (2027-2032) & (K Units)
Table 72. Global Pharmaceutical Excipients for Non-injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 73. Global Pharmaceutical Excipients for Non-injection Sales Forecast by Application (2027-2032) & (K Units)
Table 74. Global Pharmaceutical Excipients for Non-injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 75. Dow Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors
Table 76. Dow Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
Table 77. Dow Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 78. Dow Main Business
Table 79. Dow Latest Developments
Table 80. Nippon Fine Chemical Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors
Table 81. Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
Table 82. Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 83. Nippon Fine Chemical Main Business
Table 84. Nippon Fine Chemical Latest Developments
Table 85. Nanjing Well Pharmaceutical Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors
Table 86. Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
Table 87. Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. Nanjing Well Pharmaceutical Main Business
Table 89. Nanjing Well Pharmaceutical Latest Developments
Table 90. Jiangsu Maxim Biological Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors
Table 91. Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
Table 92. Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Jiangsu Maxim Biological Main Business
Table 94. Jiangsu Maxim Biological Latest Developments
Table 95. NOF Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors
Table 96. NOF Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
Table 97. NOF Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. NOF Main Business
Table 99. NOF Latest Developments
Table 100. Croda Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors
Table 101. Croda Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
Table 102. Croda Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Croda Main Business
Table 104. Croda Latest Developments
Table 105. Jiangsu Poly Pharmaceutical Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors
Table 106. Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
Table 107. Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. Jiangsu Poly Pharmaceutical Main Business
Table 109. Jiangsu Poly Pharmaceutical Latest Developments
Table 110. Er Kang Pharmaceutical Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors
Table 111. Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
Table 112. Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. Er Kang Pharmaceutical Main Business
Table 114. Er Kang Pharmaceutical Latest Developments
Table 115. Guangzhou Hanfang Pharmaceutical Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors
Table 116. Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
Table 117. Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. Guangzhou Hanfang Pharmaceutical Main Business
Table 119. Guangzhou Hanfang Pharmaceutical Latest Developments
Table 120. Pfanstiehl Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors
Table 121. Pfanstiehl Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
Table 122. Pfanstiehl Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. Pfanstiehl Main Business
Table 124. Pfanstiehl Latest Developments
Table 125. Xi'an Libang Pharmaceutical Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors
Table 126. Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
Table 127. Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 128. Xi'an Libang Pharmaceutical Main Business
Table 129. Xi'an Libang Pharmaceutical Latest Developments
Table 130. Zhejiang Tianyushan Medicinal Oil Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors
Table 131. Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
Table 132. Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 133. Zhejiang Tianyushan Medicinal Oil Main Business
Table 134. Zhejiang Tianyushan Medicinal Oil Latest Developments
Table 1. Pharmaceutical Excipients for Non-injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Pharmaceutical Excipients for Non-injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Binders
Table 4. Major Players of Disintegrants
Table 5. Major Players of Lubricants
Table 6. Major Players of Fillers
Table 7. Major Players of Others
Table 8. Global Pharmaceutical Excipients for Non-injection Sales by Type (2021-2026) & (K Units)
Table 9. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Type (2021-2026)
Table 10. Global Pharmaceutical Excipients for Non-injection Revenue by Type (2021-2026) & ($ million)
Table 11. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Type (2021-2026)
Table 12. Global Pharmaceutical Excipients for Non-injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 13. Global Pharmaceutical Excipients for Non-injection Sale by Application (2021-2026) & (K Units)
Table 14. Global Pharmaceutical Excipients for Non-injection Sale Market Share by Application (2021-2026)
Table 15. Global Pharmaceutical Excipients for Non-injection Revenue by Application (2021-2026) & ($ million)
Table 16. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Application (2021-2026)
Table 17. Global Pharmaceutical Excipients for Non-injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 18. Global Pharmaceutical Excipients for Non-injection Sales by Company (2021-2026) & (K Units)
Table 19. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Company (2021-2026)
Table 20. Global Pharmaceutical Excipients for Non-injection Revenue by Company (2021-2026) & ($ millions)
Table 21. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Company (2021-2026)
Table 22. Global Pharmaceutical Excipients for Non-injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 23. Key Manufacturers Pharmaceutical Excipients for Non-injection Producing Area Distribution and Sales Area
Table 24. Players Pharmaceutical Excipients for Non-injection Products Offered
Table 25. Pharmaceutical Excipients for Non-injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Pharmaceutical Excipients for Non-injection Sales by Geographic Region (2021-2026) & (K Units)
Table 29. Global Pharmaceutical Excipients for Non-injection Sales Market Share Geographic Region (2021-2026)
Table 30. Global Pharmaceutical Excipients for Non-injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 31. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Geographic Region (2021-2026)
Table 32. Global Pharmaceutical Excipients for Non-injection Sales by Country/Region (2021-2026) & (K Units)
Table 33. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Country/Region (2021-2026)
Table 34. Global Pharmaceutical Excipients for Non-injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 35. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Country/Region (2021-2026)
Table 36. Americas Pharmaceutical Excipients for Non-injection Sales by Country (2021-2026) & (K Units)
Table 37. Americas Pharmaceutical Excipients for Non-injection Sales Market Share by Country (2021-2026)
Table 38. Americas Pharmaceutical Excipients for Non-injection Revenue by Country (2021-2026) & ($ millions)
Table 39. Americas Pharmaceutical Excipients for Non-injection Sales by Type (2021-2026) & (K Units)
Table 40. Americas Pharmaceutical Excipients for Non-injection Sales by Application (2021-2026) & (K Units)
Table 41. APAC Pharmaceutical Excipients for Non-injection Sales by Region (2021-2026) & (K Units)
Table 42. APAC Pharmaceutical Excipients for Non-injection Sales Market Share by Region (2021-2026)
Table 43. APAC Pharmaceutical Excipients for Non-injection Revenue by Region (2021-2026) & ($ millions)
Table 44. APAC Pharmaceutical Excipients for Non-injection Sales by Type (2021-2026) & (K Units)
Table 45. APAC Pharmaceutical Excipients for Non-injection Sales by Application (2021-2026) & (K Units)
Table 46. Europe Pharmaceutical Excipients for Non-injection Sales by Country (2021-2026) & (K Units)
Table 47. Europe Pharmaceutical Excipients for Non-injection Revenue by Country (2021-2026) & ($ millions)
Table 48. Europe Pharmaceutical Excipients for Non-injection Sales by Type (2021-2026) & (K Units)
Table 49. Europe Pharmaceutical Excipients for Non-injection Sales by Application (2021-2026) & (K Units)
Table 50. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales by Country (2021-2026) & (K Units)
Table 51. Middle East & Africa Pharmaceutical Excipients for Non-injection Revenue Market Share by Country (2021-2026)
Table 52. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales by Type (2021-2026) & (K Units)
Table 53. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales by Application (2021-2026) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Pharmaceutical Excipients for Non-injection
Table 55. Key Market Challenges & Risks of Pharmaceutical Excipients for Non-injection
Table 56. Key Industry Trends of Pharmaceutical Excipients for Non-injection
Table 57. Pharmaceutical Excipients for Non-injection Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Pharmaceutical Excipients for Non-injection Distributors List
Table 60. Pharmaceutical Excipients for Non-injection Customer List
Table 61. Global Pharmaceutical Excipients for Non-injection Sales Forecast by Region (2027-2032) & (K Units)
Table 62. Global Pharmaceutical Excipients for Non-injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 63. Americas Pharmaceutical Excipients for Non-injection Sales Forecast by Country (2027-2032) & (K Units)
Table 64. Americas Pharmaceutical Excipients for Non-injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 65. APAC Pharmaceutical Excipients for Non-injection Sales Forecast by Region (2027-2032) & (K Units)
Table 66. APAC Pharmaceutical Excipients for Non-injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 67. Europe Pharmaceutical Excipients for Non-injection Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Europe Pharmaceutical Excipients for Non-injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales Forecast by Country (2027-2032) & (K Units)
Table 70. Middle East & Africa Pharmaceutical Excipients for Non-injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. Global Pharmaceutical Excipients for Non-injection Sales Forecast by Type (2027-2032) & (K Units)
Table 72. Global Pharmaceutical Excipients for Non-injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 73. Global Pharmaceutical Excipients for Non-injection Sales Forecast by Application (2027-2032) & (K Units)
Table 74. Global Pharmaceutical Excipients for Non-injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 75. Dow Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors
Table 76. Dow Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
Table 77. Dow Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 78. Dow Main Business
Table 79. Dow Latest Developments
Table 80. Nippon Fine Chemical Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors
Table 81. Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
Table 82. Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 83. Nippon Fine Chemical Main Business
Table 84. Nippon Fine Chemical Latest Developments
Table 85. Nanjing Well Pharmaceutical Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors
Table 86. Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
Table 87. Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. Nanjing Well Pharmaceutical Main Business
Table 89. Nanjing Well Pharmaceutical Latest Developments
Table 90. Jiangsu Maxim Biological Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors
Table 91. Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
Table 92. Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Jiangsu Maxim Biological Main Business
Table 94. Jiangsu Maxim Biological Latest Developments
Table 95. NOF Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors
Table 96. NOF Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
Table 97. NOF Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. NOF Main Business
Table 99. NOF Latest Developments
Table 100. Croda Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors
Table 101. Croda Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
Table 102. Croda Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Croda Main Business
Table 104. Croda Latest Developments
Table 105. Jiangsu Poly Pharmaceutical Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors
Table 106. Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
Table 107. Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. Jiangsu Poly Pharmaceutical Main Business
Table 109. Jiangsu Poly Pharmaceutical Latest Developments
Table 110. Er Kang Pharmaceutical Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors
Table 111. Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
Table 112. Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. Er Kang Pharmaceutical Main Business
Table 114. Er Kang Pharmaceutical Latest Developments
Table 115. Guangzhou Hanfang Pharmaceutical Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors
Table 116. Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
Table 117. Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. Guangzhou Hanfang Pharmaceutical Main Business
Table 119. Guangzhou Hanfang Pharmaceutical Latest Developments
Table 120. Pfanstiehl Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors
Table 121. Pfanstiehl Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
Table 122. Pfanstiehl Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. Pfanstiehl Main Business
Table 124. Pfanstiehl Latest Developments
Table 125. Xi'an Libang Pharmaceutical Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors
Table 126. Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
Table 127. Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 128. Xi'an Libang Pharmaceutical Main Business
Table 129. Xi'an Libang Pharmaceutical Latest Developments
Table 130. Zhejiang Tianyushan Medicinal Oil Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors
Table 131. Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications
Table 132. Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 133. Zhejiang Tianyushan Medicinal Oil Main Business
Table 134. Zhejiang Tianyushan Medicinal Oil Latest Developments
LIST OF FIGURES
Figure 1. Picture of Pharmaceutical Excipients for Non-injection
Figure 2. Pharmaceutical Excipients for Non-injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pharmaceutical Excipients for Non-injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Pharmaceutical Excipients for Non-injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Pharmaceutical Excipients for Non-injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Pharmaceutical Excipients for Non-injection Sales Market Share by Country/Region (2025)
Figure 10. Pharmaceutical Excipients for Non-injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Binders
Figure 12. Product Picture of Disintegrants
Figure 13. Product Picture of Lubricants
Figure 14. Product Picture of Fillers
Figure 15. Product Picture of Others
Figure 16. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Type in 2026
Figure 17. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Type (2021-2026)
Figure 18. Pharmaceutical Excipients for Non-injection Consumed inTablets
Figure 19. Global Pharmaceutical Excipients for Non-injection Market:Tablets (2021-2026) & (K Units)
Figure 20. Pharmaceutical Excipients for Non-injection Consumed in Capsules
Figure 21. Global Pharmaceutical Excipients for Non-injection Market: Capsules (2021-2026) & (K Units)
Figure 22. Pharmaceutical Excipients for Non-injection Consumed in Oral Liquids
Figure 23. Global Pharmaceutical Excipients for Non-injection Market: Oral Liquids (2021-2026) & (K Units)
Figure 24. Pharmaceutical Excipients for Non-injection Consumed in Others
Figure 25. Global Pharmaceutical Excipients for Non-injection Market: Others (2021-2026) & (K Units)
Figure 26. Global Pharmaceutical Excipients for Non-injection Sale Market Share by Application (2025)
Figure 27. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Application in 2026
Figure 28. Pharmaceutical Excipients for Non-injection Sales by Company in 2026 (K Units)
Figure 29. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Company in 2026
Figure 30. Pharmaceutical Excipients for Non-injection Revenue by Company in 2026 ($ millions)
Figure 31. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Company in 2026
Figure 32. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Geographic Region (2021-2026)
Figure 33. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Geographic Region in 2026
Figure 34. Americas Pharmaceutical Excipients for Non-injection Sales 2021-2026 (K Units)
Figure 35. Americas Pharmaceutical Excipients for Non-injection Revenue 2021-2026 ($ millions)
Figure 36. APAC Pharmaceutical Excipients for Non-injection Sales 2021-2026 (K Units)
Figure 37. APAC Pharmaceutical Excipients for Non-injection Revenue 2021-2026 ($ millions)
Figure 38. Europe Pharmaceutical Excipients for Non-injection Sales 2021-2026 (K Units)
Figure 39. Europe Pharmaceutical Excipients for Non-injection Revenue 2021-2026 ($ millions)
Figure 40. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales 2021-2026 (K Units)
Figure 41. Middle East & Africa Pharmaceutical Excipients for Non-injection Revenue 2021-2026 ($ millions)
Figure 42. Americas Pharmaceutical Excipients for Non-injection Sales Market Share by Country in 2026
Figure 43. Americas Pharmaceutical Excipients for Non-injection Revenue Market Share by Country (2021-2026)
Figure 44. Americas Pharmaceutical Excipients for Non-injection Sales Market Share by Type (2021-2026)
Figure 45. Americas Pharmaceutical Excipients for Non-injection Sales Market Share by Application (2021-2026)
Figure 46. United States Pharmaceutical Excipients for Non-injection Revenue Growth 2021-2026 ($ millions)
Figure 47. Canada Pharmaceutical Excipients for Non-injection Revenue Growth 2021-2026 ($ millions)
Figure 48. Mexico Pharmaceutical Excipients for Non-injection Revenue Growth 2021-2026 ($ millions)
Figure 49. Brazil Pharmaceutical Excipients for Non-injection Revenue Growth 2021-2026 ($ millions)
Figure 50. APAC Pharmaceutical Excipients for Non-injection Sales Market Share by Region in 2026
Figure 51. APAC Pharmaceutical Excipients for Non-injection Revenue Market Share by Region (2021-2026)
Figure 52. APAC Pharmaceutical Excipients for Non-injection Sales Market Share by Type (2021-2026)
Figure 53. APAC Pharmaceutical Excipients for Non-injection Sales Market Share by Application (2021-2026)
Figure 54. China Pharmaceutical Excipients for Non-injection Revenue Growth 2021-2026 ($ millions)
Figure 55. Japan Pharmaceutical Excipients for Non-injection Revenue Growth 2021-2026 ($ millions)
Figure 56. South Korea Pharmaceutical Excipients for Non-injection Revenue Growth 2021-2026 ($ millions)
Figure 57. Southeast Asia Pharmaceutical Excipients for Non-injection Revenue Growth 2021-2026 ($ millions)
Figure 58. India Pharmaceutical Excipients for Non-injection Revenue Growth 2021-2026 ($ millions)
Figure 59. Australia Pharmaceutical Excipients for Non-injection Revenue Growth 2021-2026 ($ millions)
Figure 60. China Taiwan Pharmaceutical Excipients for Non-injection Revenue Growth 2021-2026 ($ millions)
Figure 61. Europe Pharmaceutical Excipients for Non-injection Sales Market Share by Country in 2026
Figure 62. Europe Pharmaceutical Excipients for Non-injection Revenue Market Share by Country (2021-2026)
Figure 63. Europe Pharmaceutical Excipients for Non-injection Sales Market Share by Type (2021-2026)
Figure 64. Europe Pharmaceutical Excipients for Non-injection Sales Market Share by Application (2021-2026)
Figure 65. Germany Pharmaceutical Excipients for Non-injection Revenue Growth 2021-2026 ($ millions)
Figure 66. France Pharmaceutical Excipients for Non-injection Revenue Growth 2021-2026 ($ millions)
Figure 67. UK Pharmaceutical Excipients for Non-injection Revenue Growth 2021-2026 ($ millions)
Figure 68. Italy Pharmaceutical Excipients for Non-injection Revenue Growth 2021-2026 ($ millions)
Figure 69. Russia Pharmaceutical Excipients for Non-injection Revenue Growth 2021-2026 ($ millions)
Figure 70. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales Market Share by Country (2021-2026)
Figure 71. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales Market Share by Type (2021-2026)
Figure 72. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales Market Share by Application (2021-2026)
Figure 73. Egypt Pharmaceutical Excipients for Non-injection Revenue Growth 2021-2026 ($ millions)
Figure 74. South Africa Pharmaceutical Excipients for Non-injection Revenue Growth 2021-2026 ($ millions)
Figure 75. Israel Pharmaceutical Excipients for Non-injection Revenue Growth 2021-2026 ($ millions)
Figure 76. Turkey Pharmaceutical Excipients for Non-injection Revenue Growth 2021-2026 ($ millions)
Figure 77. GCC Countries Pharmaceutical Excipients for Non-injection Revenue Growth 2021-2026 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Pharmaceutical Excipients for Non-injection in 2026
Figure 79. Manufacturing Process Analysis of Pharmaceutical Excipients for Non-injection
Figure 80. Industry Chain Structure of Pharmaceutical Excipients for Non-injection
Figure 81. Channels of Distribution
Figure 82. Global Pharmaceutical Excipients for Non-injection Sales Market Forecast by Region (2027-2032)
Figure 83. Global Pharmaceutical Excipients for Non-injection Revenue Market Share Forecast by Region (2027-2032)
Figure 84. Global Pharmaceutical Excipients for Non-injection Sales Market Share Forecast by Type (2027-2032)
Figure 85. Global Pharmaceutical Excipients for Non-injection Revenue Market Share Forecast by Type (2027-2032)
Figure 86. Global Pharmaceutical Excipients for Non-injection Sales Market Share Forecast by Application (2027-2032)
Figure 87. Global Pharmaceutical Excipients for Non-injection Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Pharmaceutical Excipients for Non-injection
Figure 2. Pharmaceutical Excipients for Non-injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pharmaceutical Excipients for Non-injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Pharmaceutical Excipients for Non-injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Pharmaceutical Excipients for Non-injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Pharmaceutical Excipients for Non-injection Sales Market Share by Country/Region (2025)
Figure 10. Pharmaceutical Excipients for Non-injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Binders
Figure 12. Product Picture of Disintegrants
Figure 13. Product Picture of Lubricants
Figure 14. Product Picture of Fillers
Figure 15. Product Picture of Others
Figure 16. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Type in 2026
Figure 17. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Type (2021-2026)
Figure 18. Pharmaceutical Excipients for Non-injection Consumed inTablets
Figure 19. Global Pharmaceutical Excipients for Non-injection Market:Tablets (2021-2026) & (K Units)
Figure 20. Pharmaceutical Excipients for Non-injection Consumed in Capsules
Figure 21. Global Pharmaceutical Excipients for Non-injection Market: Capsules (2021-2026) & (K Units)
Figure 22. Pharmaceutical Excipients for Non-injection Consumed in Oral Liquids
Figure 23. Global Pharmaceutical Excipients for Non-injection Market: Oral Liquids (2021-2026) & (K Units)
Figure 24. Pharmaceutical Excipients for Non-injection Consumed in Others
Figure 25. Global Pharmaceutical Excipients for Non-injection Market: Others (2021-2026) & (K Units)
Figure 26. Global Pharmaceutical Excipients for Non-injection Sale Market Share by Application (2025)
Figure 27. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Application in 2026
Figure 28. Pharmaceutical Excipients for Non-injection Sales by Company in 2026 (K Units)
Figure 29. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Company in 2026
Figure 30. Pharmaceutical Excipients for Non-injection Revenue by Company in 2026 ($ millions)
Figure 31. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Company in 2026
Figure 32. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Geographic Region (2021-2026)
Figure 33. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Geographic Region in 2026
Figure 34. Americas Pharmaceutical Excipients for Non-injection Sales 2021-2026 (K Units)
Figure 35. Americas Pharmaceutical Excipients for Non-injection Revenue 2021-2026 ($ millions)
Figure 36. APAC Pharmaceutical Excipients for Non-injection Sales 2021-2026 (K Units)
Figure 37. APAC Pharmaceutical Excipients for Non-injection Revenue 2021-2026 ($ millions)
Figure 38. Europe Pharmaceutical Excipients for Non-injection Sales 2021-2026 (K Units)
Figure 39. Europe Pharmaceutical Excipients for Non-injection Revenue 2021-2026 ($ millions)
Figure 40. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales 2021-2026 (K Units)
Figure 41. Middle East & Africa Pharmaceutical Excipients for Non-injection Revenue 2021-2026 ($ millions)
Figure 42. Americas Pharmaceutical Excipients for Non-injection Sales Market Share by Country in 2026
Figure 43. Americas Pharmaceutical Excipients for Non-injection Revenue Market Share by Country (2021-2026)
Figure 44. Americas Pharmaceutical Excipients for Non-injection Sales Market Share by Type (2021-2026)
Figure 45. Americas Pharmaceutical Excipients for Non-injection Sales Market Share by Application (2021-2026)
Figure 46. United States Pharmaceutical Excipients for Non-injection Revenue Growth 2021-2026 ($ millions)
Figure 47. Canada Pharmaceutical Excipients for Non-injection Revenue Growth 2021-2026 ($ millions)
Figure 48. Mexico Pharmaceutical Excipients for Non-injection Revenue Growth 2021-2026 ($ millions)
Figure 49. Brazil Pharmaceutical Excipients for Non-injection Revenue Growth 2021-2026 ($ millions)
Figure 50. APAC Pharmaceutical Excipients for Non-injection Sales Market Share by Region in 2026
Figure 51. APAC Pharmaceutical Excipients for Non-injection Revenue Market Share by Region (2021-2026)
Figure 52. APAC Pharmaceutical Excipients for Non-injection Sales Market Share by Type (2021-2026)
Figure 53. APAC Pharmaceutical Excipients for Non-injection Sales Market Share by Application (2021-2026)
Figure 54. China Pharmaceutical Excipients for Non-injection Revenue Growth 2021-2026 ($ millions)
Figure 55. Japan Pharmaceutical Excipients for Non-injection Revenue Growth 2021-2026 ($ millions)
Figure 56. South Korea Pharmaceutical Excipients for Non-injection Revenue Growth 2021-2026 ($ millions)
Figure 57. Southeast Asia Pharmaceutical Excipients for Non-injection Revenue Growth 2021-2026 ($ millions)
Figure 58. India Pharmaceutical Excipients for Non-injection Revenue Growth 2021-2026 ($ millions)
Figure 59. Australia Pharmaceutical Excipients for Non-injection Revenue Growth 2021-2026 ($ millions)
Figure 60. China Taiwan Pharmaceutical Excipients for Non-injection Revenue Growth 2021-2026 ($ millions)
Figure 61. Europe Pharmaceutical Excipients for Non-injection Sales Market Share by Country in 2026
Figure 62. Europe Pharmaceutical Excipients for Non-injection Revenue Market Share by Country (2021-2026)
Figure 63. Europe Pharmaceutical Excipients for Non-injection Sales Market Share by Type (2021-2026)
Figure 64. Europe Pharmaceutical Excipients for Non-injection Sales Market Share by Application (2021-2026)
Figure 65. Germany Pharmaceutical Excipients for Non-injection Revenue Growth 2021-2026 ($ millions)
Figure 66. France Pharmaceutical Excipients for Non-injection Revenue Growth 2021-2026 ($ millions)
Figure 67. UK Pharmaceutical Excipients for Non-injection Revenue Growth 2021-2026 ($ millions)
Figure 68. Italy Pharmaceutical Excipients for Non-injection Revenue Growth 2021-2026 ($ millions)
Figure 69. Russia Pharmaceutical Excipients for Non-injection Revenue Growth 2021-2026 ($ millions)
Figure 70. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales Market Share by Country (2021-2026)
Figure 71. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales Market Share by Type (2021-2026)
Figure 72. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales Market Share by Application (2021-2026)
Figure 73. Egypt Pharmaceutical Excipients for Non-injection Revenue Growth 2021-2026 ($ millions)
Figure 74. South Africa Pharmaceutical Excipients for Non-injection Revenue Growth 2021-2026 ($ millions)
Figure 75. Israel Pharmaceutical Excipients for Non-injection Revenue Growth 2021-2026 ($ millions)
Figure 76. Turkey Pharmaceutical Excipients for Non-injection Revenue Growth 2021-2026 ($ millions)
Figure 77. GCC Countries Pharmaceutical Excipients for Non-injection Revenue Growth 2021-2026 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Pharmaceutical Excipients for Non-injection in 2026
Figure 79. Manufacturing Process Analysis of Pharmaceutical Excipients for Non-injection
Figure 80. Industry Chain Structure of Pharmaceutical Excipients for Non-injection
Figure 81. Channels of Distribution
Figure 82. Global Pharmaceutical Excipients for Non-injection Sales Market Forecast by Region (2027-2032)
Figure 83. Global Pharmaceutical Excipients for Non-injection Revenue Market Share Forecast by Region (2027-2032)
Figure 84. Global Pharmaceutical Excipients for Non-injection Sales Market Share Forecast by Type (2027-2032)
Figure 85. Global Pharmaceutical Excipients for Non-injection Revenue Market Share Forecast by Type (2027-2032)
Figure 86. Global Pharmaceutical Excipients for Non-injection Sales Market Share Forecast by Application (2027-2032)
Figure 87. Global Pharmaceutical Excipients for Non-injection Revenue Market Share Forecast by Application (2027-2032)
